BANK VONTOBEL/CALL/MERCK & CO./125/0.1/20.09.24 Stock

Warrant

DE000VM7N4X7

Market Closed - Deutsche Boerse AG 14:03:34 2024-05-13 EDT
0.83 EUR -11.70% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./125/0.1/20.09.24
Current month-3.09%
1 month+13.25%
Date Price Change Volume
24-05-13 0.83 -11.70% 0
24-05-10 0.94 +1.08% 0
24-05-09 0.93 +2.20% 0
24-05-08 0.91 +5.81% 0
24-05-07 0.86 +10.26% 0

Delayed Quote Deutsche Boerse AG

Last update May 13, 2024 at 02:03 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM7N4X
ISINDE000VM7N4X7
Date issued 2023-12-29
Strike 125 $
Maturity 2024-09-20 (130 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.23
Lowest since issue 0.222
Spread 0.01
Spread %1.18%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW